Reproductive Biology and Endocrinology最新文献

筛选
英文 中文
A novel approach to treating Endometriosis-Related Repeated IVF failures- insights from single case report. 一种治疗子宫内膜异位症相关的重复IVF失败的新方法-来自单个病例报告的见解。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-09-24 DOI: 10.1186/s12958-026-01610-4
Raoul Orvieto
{"title":"A novel approach to treating Endometriosis-Related Repeated IVF failures- insights from single case report.","authors":"Raoul Orvieto","doi":"10.1186/s12958-026-01610-4","DOIUrl":"10.1186/s12958-026-01610-4","url":null,"abstract":"<p><p>This report explores the case of a young, normal-responder nulligravida with peritoneal endometriosis and recurrent implantation failure, with poor embryo quality during multiple failed attempts at IVF treatment. The patient underwent Dienogest (Visabelle®) pretreatment followed by a combination protocol of Stop GnRH-agonist/GnRH-antagonist for controlled ovarian stimulation, culminating in a natural cycle frozen-thawed embryo transfer with modified luteal phase support. This combined approach produced several high-quality embryos leading to a successful singleton pregnancy. These findings provide new insights into addressing endometriosis-associated infertility and repeated IVF failure.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13602600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149040373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of animal models on translating male infertility research from bench to bedside: a narrative review. 动物模型对男性不育症研究从实验室到临床的影响:一个叙述性的回顾。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-09-15 DOI: 10.1186/s12958-026-01607-z
Shengnan Li, Tengfei Chen, Hongyan Chen, Boxian Gao, Chongfu Zhong
{"title":"The impact of animal models on translating male infertility research from bench to bedside: a narrative review.","authors":"Shengnan Li, Tengfei Chen, Hongyan Chen, Boxian Gao, Chongfu Zhong","doi":"10.1186/s12958-026-01607-z","DOIUrl":"10.1186/s12958-026-01607-z","url":null,"abstract":"<p><p>Male infertility (MI) represents a complex clinical issue affecting millions of couples worldwide. Its diverse etiologies and incompletely elucidated mechanisms limit the development of effective therapeutic strategies. Animal models, serving as a bridge between basic research and clinical practice, play an indispensable role in simulating the pathophysiological processes of human MI, deciphering key underlying mechanisms, and screening and evaluating potential therapeutic agents. This review systematically summarizes the various animal models employed in MI research, including chemically induced models (e.g., using tripterygium glycosides or cyclophosphamide), endocrine-disrupting agent-induced models (e.g., using Bisphenol A (BPA) or finasteride), and physically induced models (e.g., via heat stress or experimental varicocele). We focus on elucidating the core pathological mechanisms these models recapitulate, encompassing oxidative stress, inflammatory responses, novel cell death pathways such as apoptosis, pyroptosis, and ferroptosis, as well as endocrine disruption of the hypothalamic-pituitary-gonadal (HPG) axis. Through an in-depth analysis of the characteristics of each model, associated signaling pathways-including the nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) pathway, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, and the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome, and identified pharmacological targets, this article aims to provide insights into the complex etiology of human MI and offer a crucial theoretical foundation and experimental framework for the development and translation of novel mechanism-based therapeutics.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-IVF lifestyle intervention and reproductive outcomes in women with overweight or obesity undergoing IVF: a randomized clinical trial. 接受体外受精的超重或肥胖妇女的体外受精前生活方式干预和生殖结果:一项随机临床试验
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-19 DOI: 10.1186/s12958-026-01597-y
Jichun Tan, Siru Hou, Shanshan Wu, Siwen Zhang, Xing Xin, Shan Gao, Yumeng Feng, Jiansu Bian, Xiaoyu Yan, Xudong Zhang
{"title":"Pre-IVF lifestyle intervention and reproductive outcomes in women with overweight or obesity undergoing IVF: a randomized clinical trial.","authors":"Jichun Tan, Siru Hou, Shanshan Wu, Siwen Zhang, Xing Xin, Shan Gao, Yumeng Feng, Jiansu Bian, Xiaoyu Yan, Xudong Zhang","doi":"10.1186/s12958-026-01597-y","DOIUrl":"https://doi.org/10.1186/s12958-026-01597-y","url":null,"abstract":"<p><strong>Background: </strong>Obesity is associated with reduced female fertility and poorer in vitro fertilization (IVF) outcomes. Although pre-IVF lifestyle-based weight loss is commonly recommended for women with overweight or obesity, whether specific strategies improve reproductive outcomes remains uncertain. We compared two pre-IVF lifestyle interventions with usual care in women undergoing IVF.</p><p><strong>Methods: </strong>In this single-center, parallel-group randomized clinical trial conducted at Shengjing Hospital of China Medical University, Shenyang, China, women aged 20-38 years with a body mass index (BMI) of 24-40 kg/m² planning IVF were randomly assigned in a 1:1:1 ratio to 12-hour time-restricted feeding plus moderate physical activity (TRF + PA), a calorie-restricted diet (CRD), or usual care. Recruitment took place from March 14, 2023, to August 20, 2024, and follow-up was completed on February 20, 2026. The primary outcome was cumulative live birth. Secondary outcomes included cumulative clinical pregnancy, miscarriage, obstetric complications, embryological outcomes, anthropometric changes, and metabolic measures.</p><p><strong>Results: </strong>A total of 273 women underwent randomization. Cumulative live birth did not differ between groups, occurring in 46.6% of women in the TRF + PA group, 43.8% in the CRD group, and 44.0% in the control group (P = 0.916). After adjustment for baseline waist circumference, neither intervention was associated with cumulative live birth compared with usual care (TRF + PA vs. control: adjusted risk ratio [aRR] 1.034; 95% CI, 0.746-1.434; P = 0.839; CRD vs. control: aRR 0.936; 95% CI, 0.676-1.295; P = 0.689). TRF + PA was associated with a greater reduction in homeostasis model assessment of insulin resistance (HOMA-IR) than usual care (P = 0.005). In analyses treating anthropometric change as a continuous exposure, greater reduction in body fat percentage was independently associated with a higher probability of live birth (per 1-percentage-point reduction: aRR 1.065; 95% CI, 1.021-1.111; P = 0.003). Exploratory spline analyses suggested a threshold, with higher live birth probability observed above an absolute reduction of 5.16% points in body fat percentage.</p><p><strong>Conclusions: </strong>Among women with overweight or obesity undergoing IVF, pre-IVF lifestyle intervention did not improve cumulative live birth compared with usual care. However, reduction in body fat percentage was independently associated with live birth, suggesting that change in adiposity may be more relevant to reproductive outcomes than weight loss alone.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry, ChiCTR2500112593. Registered on November 17, 2025; retrospectively registered.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13761003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A proposal to meet specific criteria before fully integrating Artificial Intelligence (AI) into the IVF lab. 在将人工智能(AI)完全整合到试管婴儿实验室之前,应满足特定标准的建议。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-19 DOI: 10.1186/s12958-026-01591-4
David B Seifer, Charles L Bormann
{"title":"A proposal to meet specific criteria before fully integrating Artificial Intelligence (AI) into the IVF lab.","authors":"David B Seifer, Charles L Bormann","doi":"10.1186/s12958-026-01591-4","DOIUrl":"https://doi.org/10.1186/s12958-026-01591-4","url":null,"abstract":"<p><p>Artificial intelligence (AI) is generating genuine excitement in reproductive medicine for good reason. The promise of more consistent embryo assessment, reduced inter-observer variability, better outcome prediction and meaningful support for the embryologist's judgment represents a real opportunity to improve care for patients who have already invested enormously in the pursuit of a family. Realizing that promise, however, depends on something the field has not always done well which is insisting on rigorous validation before widespread adoption. This editorial is written in that spirit, as advocates for AI who believe the technology's long-term acceptance by patients, clinicians and embryologists will be determined by how carefully we deploy it now and how we proceed going forward. How will we know when AI is ready to fully deploy in the IVF lab? The answer requires distinguishing between being safe and being safe and effective and the medical community has not yet reached consensus on either standard for most applications. Professional societies will need to lead that process. However, in the meantime, with commercial adoption accelerating and stakeholder incentives not always aligned with patient welfare, we propose criteria as a starting framework for that discussion.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13488256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148797624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-blastomere next-generation sequencing confirms chromosomal abnormalities as the primary cause of impaired developmental potential in embryos with abnormal cleavage patterns. 单卵裂球下一代测序证实染色体异常是卵裂模式异常的胚胎发育潜力受损的主要原因。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-18 DOI: 10.1186/s12958-026-01606-0
Haifang Liu, Shikai Wang, Xianbao Mao, Pingpin Wei, Zhengda Li, Xiaohui Zhang, Liangshi Chen, Yueyue Huang, Wen Shi, Lintao Xue
{"title":"Single-blastomere next-generation sequencing confirms chromosomal abnormalities as the primary cause of impaired developmental potential in embryos with abnormal cleavage patterns.","authors":"Haifang Liu, Shikai Wang, Xianbao Mao, Pingpin Wei, Zhengda Li, Xiaohui Zhang, Liangshi Chen, Yueyue Huang, Wen Shi, Lintao Xue","doi":"10.1186/s12958-026-01606-0","DOIUrl":"https://doi.org/10.1186/s12958-026-01606-0","url":null,"abstract":"<p><strong>Background: </strong>Abnormal cleavage impairs embryonic development, but the effects of different abnormal cleavage patterns and occurrence stages remain unclear. Previous chromosomal analyses at the blastocyst stage have failed to elucidate the underlying mechanism. This study investigated the effects of abnormal cleavage patterns and occurrence stages on embryonic developmental potential and clarified the association between abnormal cleavage and chromosomal abnormalities through single-blastomere sequencing.</p><p><strong>Methods: </strong>Time-lapse data were retrospectively analysed to assess embryonic development. The embryos were divided into normal cleavage (NC), direct cleavage (DC), chaotic cleavage (CC), reverse cleavage (RC) and multinucleation (MN) groups based on their cleavage patterns and into subgroups 1, 2 and 3 based on the first three division cycles of abnormal cleavage. To establish a novel single-blastomere continuous culture and isolation (SBCCI) system, 2PN zygotes derived from in vitro-matured MI oocytes were prospectively collected. Following zona pellucida removal, they were monitored via time-lapse. During the first three division cycles, blastomeres exhibiting different cleavage patterns were subjected to next-generation sequencing to analyse their chromosomal status at the single-blastomere level.</p><p><strong>Results: </strong>Compared with the normal cleavage group, the abnormal cleavage group presented significantly lower developmental indicators (all P < 0.05). The blastocyst and high-quality blastocyst formation rates were significantly lower in the DC and CC groups than in the RC and MN groups (all P < 0.05). The DC1 and RC1 subgroups had significantly lower blastocyst formation rates than the DC2/3 and RC2/3 subgroup (all P < 0.05). The amplification success rate in the CC group and the detection success rate in the DC group were significantly lower than those in the other groups (all P < 0.05). The chromosomal abnormality rate was significantly greater in the abnormal cleavage groups than in the normal cleavage group (P < 0.05). The chromosomal abnormality rates were the highest in the DC and CC groups (100.00% and 86.96%, respectively). The euploidy rates were significantly lower in the NC1 group than in the NC3 group (P < 0.05).</p><p><strong>Conclusions: </strong>Abnormal cleavage can significantly impair embryonic development, and its effects vary depending on the pattern and occurrence stage. Critically, we demonstrated that chromosomal abnormalities induced by abnormal cleavage are negatively associated with embryonic development.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13756974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproductive factors and mortality risk: insights from the Tehran Lipid and Glucose Study (TLGS). 生殖因素和死亡风险:来自德黑兰脂质和葡萄糖研究(TLGS)的见解。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-12 DOI: 10.1186/s12958-026-01604-2
Paria Pezhdam, Fahimeh Ramezani Tehrani, Marzieh Saei Ghare Naz, Mahbanoo Farhadi-Azar, Maryam Farahmand, Fereidoun Azizi, Maryam Mousavi
{"title":"Reproductive factors and mortality risk: insights from the Tehran Lipid and Glucose Study (TLGS).","authors":"Paria Pezhdam, Fahimeh Ramezani Tehrani, Marzieh Saei Ghare Naz, Mahbanoo Farhadi-Azar, Maryam Farahmand, Fereidoun Azizi, Maryam Mousavi","doi":"10.1186/s12958-026-01604-2","DOIUrl":"10.1186/s12958-026-01604-2","url":null,"abstract":"<p><strong>Background: </strong>While reproductive history is recognized as a determinant of women's long-term health, its impact on mortality risk remains poorly characterized. This study aimed to elucidate the association between key reproductive factors and subsequent all-cause and cause-specific mortality within the Tehran Lipid and Glucose Study (TLGS) population.</p><p><strong>Methods: </strong>We analyzed data from a prospective cohort of 5,165 women (aged ≥ 20 years) with a history of at least one pregnancy. Associations between reproductive factors and mortality were estimated using Cox proportional hazards regression models, adjusting for age, body mass index (BMI), smoking status, education, physical activity levels, diabetes history, hypertension history, and dyslipidemia.</p><p><strong>Results: </strong>Over the follow-up period, 497 deaths were recorded, representing 9.6% of participants; 168 deaths were due to cardiovascular disease (CVD) and 96 to cancer, accounting for 33.8% and 19.4% of all deaths, respectively. Late menarche was associated with increased all-cause and cancer-related mortality, with adjusted hazard ratios (HRs) of 1.52 and 2.04, respectively. Recurrent abortion was associated with higher all-cause mortality (HR = 1.41; 95% CI: 1.12-1.77). Women with parity ≥ 3 had higher risks of all-cause, cardiovascular, and cancer-related mortality compared with those with parity 1-2.</p><p><strong>Conclusion: </strong>Reproductive characteristics, particularly late menarche, recurrent abortion, and high parity, were associated with increased long-term mortality risk. These findings support further investigation of reproductive characteristics as potential markers of long-term mortality risk.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149380478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female infertility in nonclassic congenital adrenal hyperplasia: beyond hyperandrogenism. 非典型性先天性肾上腺增生的女性不孕症:超出雄激素过多。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-08 DOI: 10.1186/s12958-026-01603-3
Shimin Wang, Xinhong Li, Ningxin Zhang, Xiuping Zhang, Xueqing Wu
{"title":"Female infertility in nonclassic congenital adrenal hyperplasia: beyond hyperandrogenism.","authors":"Shimin Wang, Xinhong Li, Ningxin Zhang, Xiuping Zhang, Xueqing Wu","doi":"10.1186/s12958-026-01603-3","DOIUrl":"10.1186/s12958-026-01603-3","url":null,"abstract":"<p><p>Nonclassic congenital adrenal hyperplasia (NCCAH) is a common autosomal recessive endocrinopathy, primarily caused by partial 21-hydroxylase (CYP21A2) deficiency, and represents a significant but often underrecognized cause of female infertility. Clinically, affected women frequently present with hyperandrogenism, menstrual irregularities, and ovulatory dysfunction, which can lead to misdiagnosis as polycystic ovary syndrome (PCOS). Traditionally, reproductive failure in NCCAH has been attributed solely to androgen excess disrupting folliculogenesis. However, recent evidence reveals a multifactorial pathophysiology. Beyond hyperandrogenism, premature follicular-phase progesterone elevation, disruption of the hypothalamic-pituitary-ovarian (HPO) axis, impaired endometrial receptivity, and increased risk of early pregnancy loss collectively contribute to infertility. Accurate diagnosis requires a structured approach, including basal and adrenocorticotropic hormone (ACTH)-stimulated 17-hydroxyprogesterone (17-OHP) measurement, comprehensive endocrine profiling, and genetic testing. Therefore, fertility optimization should extend beyond isolated androgen suppression. This review critically summarizes current knowledge of NCCAH-related infertility mechanisms and proposes an integrated, multidisciplinary management strategy-encompassing targeted targeted glucocorticoid (GC) therapy, ovulation induction, assisted reproductive technology (ART), careful obstetric monitoring, and genetic counseling-to improve fertility and pregnancy outcomes in this patient population.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149335140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of ejaculatory abstinence duration on laboratory semen parameters: a systematic review and meta-analysis of human studies. 禁欲时间对实验室精液参数的影响:人类研究的系统回顾和荟萃分析。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-06 DOI: 10.1186/s12958-026-01602-4
Bakhtiyar Serik, Riza Sharapatova, Akylbek Pshenbayev, Aizhan Ormankyzy, Nadiar M Mussin, Kulyash R Zhilisbayeva, Akmaral Baspakova, Amin Tamadon
{"title":"Effect of ejaculatory abstinence duration on laboratory semen parameters: a systematic review and meta-analysis of human studies.","authors":"Bakhtiyar Serik, Riza Sharapatova, Akylbek Pshenbayev, Aizhan Ormankyzy, Nadiar M Mussin, Kulyash R Zhilisbayeva, Akmaral Baspakova, Amin Tamadon","doi":"10.1186/s12958-026-01602-4","DOIUrl":"10.1186/s12958-026-01602-4","url":null,"abstract":"<p><strong>Objective: </strong>This systematic review and meta-analysis was conducted to clarify the effects of abstinence duration on semen quality in human studies.</p><p><strong>Methods: </strong>This review was prospectively registered in PROSPERO and conducted in accordance with PRISMA 2020 guidelines. PubMed (MEDLINE), Scopus, and Web of Science were searched from inception to the most recent update. Human studies evaluating ejaculatory abstinence duration in relation to semen parameters were included. For methodological clarity, studies were classified into (1) single-ejaculate abstinence-comparison studies (paired or independent-group designs) and (2) repeated or frequent ejaculation studies involving consecutive ejaculations. Only single-ejaculate abstinence-comparison studies contributed to the primary meta-analyses. Random-effects meta-analyses were performed for semen volume, sperm concentration, total sperm count, total sperm motility, progressive sperm motility, and sperm morphology. Subgroup and sensitivity analyses were conducted, and risk of bias was assessed using ROBINS-I.</p><p><strong>Results: </strong>Eighty-two studies were included in the qualitative synthesis, of which 59 contributed to the quantitative meta-analyses. Comparisons involving longer abstinence intervals (e.g., ≥ 4-5 days compared with 2-3 days) were associated with significantly higher semen volume (MD - 1.07 mL, indicating higher volume with longer abstinence) and total sperm count (MD - 80.61 × 10⁶ sperm per ejaculate). In contrast, very short abstinence intervals were associated with significantly higher total sperm motility (MD 4.37%) and progressive sperm motility (MD 3.24%). No consistent overall differences were observed for sperm concentration or morphology across abstinence-interval contrasts. Substantial heterogeneity was observed across outcomes; however, sensitivity analyses generally produced similar directions of association, although substantial heterogeneity remained. The certainty of evidence was low or very low across outcomes, mainly because of substantial heterogeneity, residual confounding, and imprecision.</p><p><strong>Conclusions: </strong>Across explicit abstinence-interval contrasts, higher-duration intervals were associated with greater semen volume and total sperm count, whereas lower-duration intervals were associated with higher total and progressive sperm motility. The certainty of evidence was low or very low, and these results represent laboratory associations rather than causal effects or universally applicable clinical thresholds. Repeated or frequent ejaculation protocols and reproductive outcomes were synthesized narratively. Abstinence recommendations should therefore be individualized according to the purpose of semen collection and the clinical context.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13729421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of progestin-primed ovarian stimulation protocol plus clomiphene citrate in patients with low basal LH levels: a randomized controlled trial. 黄体酮刺激卵巢方案加枸橼酸克罗米芬对低基础LH水平患者的影响:一项随机对照试验。
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-06 DOI: 10.1186/s12958-026-01601-5
Zhijie Hu, Yong Fan, Xiaoqian Zhou, Haiyan Guo, Weiran Chai, Qiuju Chen, Qifeng Lyu, Renfei Cai, Xuefeng Lu
{"title":"Effects of progestin-primed ovarian stimulation protocol plus clomiphene citrate in patients with low basal LH levels: a randomized controlled trial.","authors":"Zhijie Hu, Yong Fan, Xiaoqian Zhou, Haiyan Guo, Weiran Chai, Qiuju Chen, Qifeng Lyu, Renfei Cai, Xuefeng Lu","doi":"10.1186/s12958-026-01601-5","DOIUrl":"10.1186/s12958-026-01601-5","url":null,"abstract":"<p><strong>Background: </strong>Infertile patients with low basal luteinizing hormone (LH) levels have low oocyte retrieval rate, but whether progestin-primed ovarian stimulation (PPOS) protocol with clomiphene citrate (CC) could enhance oocyte retrieval rate in these patients remains unclear.</p><p><strong>Methods: </strong>This prospective randomized controlled trial was performed between January 2018 and February 2021, included 230 infertile patients with low basal LH levels (LH < 2.27 mIU/mL). In study group, 115 patients received human menopausal gonadotropin (hMG) 150 or 225 IU/d + CC 50 mg/d + medroxyprogesterone acetate (MPA) 10 mg/d from the third day of menstruation. In control group, 115 patients received hMG 150 or 225 IU/d + MPA 10 mg/d from the third day of menstruation. Viable embryos were cryopreserved for later transfer. The primary outcome measure was the oocyte retrieval rate.</p><p><strong>Results: </strong>CC contributed to LH secretion. The hMG+MPA+CC group showed a decreased oocyte retrieval rate (0.71 ± 0.22 vs. 0.76 ± 0.18, mean difference (MD) -0.06 (-0.11 to -0.01); P = 0.043) and a decreased number of cryopreserved embryos (2.89 ± 2.43 vs. 3.90 ± 2.39, MD -0.89 (-1.50 to -0.28); FDR-P = 0.035). Two groups had similar number of retrieved oocytes (8.83 ± 5.41 vs. 10.69 ± 5.85, MD -0.99 (-2.27 to 0.29); FDR-P = 0.213) and oocyte utilization rate (0.40 ± 0.25 vs. 0.46 ± 0.24, MD -0.07 (-0.14 to -0.01); FDR-P = 0.084). Two groups had comparable cumulative clinical pregnancy rates (61.05% vs. 77.67%, hazard ratio (HR) 0.74 (0.53 to 1.06); P = 0.101; FDR-P = 0.214) and cumulative live birth rates (53.68% vs. 66.02%, HR 0.77 (0.53 to 1.13); P = 0.183; FDR-P = 0.214).</p><p><strong>Conclusions: </strong>CC contributed to LH secretion, but PPOS protocol with CC resulted in a lower oocyte retrieval rate in patients with low basal LH levels. PPOS protocol with CC should be used cautiously in these patients.</p><p><strong>Trial registration: </strong>ChiCTR number: ChiCTR1800014440. URL: https://www.chictr.org.cn/showproj.html?proj=24573 . Date of registration: 2018/01/13. Date of enrollment of the first subject: 2018/1/17.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13729595/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating plasma microRNAs as potential non-invasive biomarkers in infertile women with adenomyosis: an observational study. 循环血浆microrna作为不孕妇女子宫腺肌症潜在的非侵入性生物标志物:一项观察性研究
IF 5.7 2区 医学
Reproductive Biology and Endocrinology Pub Date : 2026-08-05 DOI: 10.1186/s12958-026-01598-x
Ana Corachán, Mar Pérez-Ferrer, Amparo Faus, Pilar Alamá, Carmen Vidal, Juan Giles, Antonio Pellicer, Juan Antonio García-Velasco, Hortensia Ferrero
{"title":"Circulating plasma microRNAs as potential non-invasive biomarkers in infertile women with adenomyosis: an observational study.","authors":"Ana Corachán, Mar Pérez-Ferrer, Amparo Faus, Pilar Alamá, Carmen Vidal, Juan Giles, Antonio Pellicer, Juan Antonio García-Velasco, Hortensia Ferrero","doi":"10.1186/s12958-026-01598-x","DOIUrl":"https://doi.org/10.1186/s12958-026-01598-x","url":null,"abstract":"<p><strong>Background: </strong>Despite advancements in imaging techniques, the non-invasive diagnosis of adenomyosis remains particularly challenging due to the overlap of imaging features with other uterine diseases, and the lack of consistent correlation with clinical presentation, with histological confirmation after hysterectomy still necessary. In this context, circulating miRNAs emerge as promising candidates for accurate non-invasive diagnosis.</p><p><strong>Methods: </strong>To determine whether women with adenomyosis exhibit a distinct circulating plasma miRNA profile that can serve as a diagnostic marker, miRNA sequencing was performed to compare the plasma miRNA profile of women with adenomyosis with infertile and healthy fertile controls (n =  10/group). Adenomyosis was diagnosed by transvaginal ultrasound using Morphological Uterus Sonographic Assessment (MUSA) criteria. Plasma and endometrial biopsies were collected during the secretory phase from women undergoing hormone replacement therapy. Total RNA was extracted from plasma, libraries were prepared using NEXTFLEX® Small RNA-Seq v4 kits, and miRNAseq was performed on the NextSeq 550 NGS platform. Differentially expressed (DE) miRNAs were identified using the edgeR method (false discovery rate < 0.05). The discriminatory potential of DEmiRNAs was evaluated by receiver operating characteristic (ROC) curve analysis using the area under the curve (AUC). Validation was performed by quantitative PCR on plasma and endometrium (n =  15/group). The target genes of DEmiRNAs were retrieved from miRTarBase and subjected to functional enrichment analysis.</p><p><strong>Results: </strong>A total of 11 disease-specific DEmiRNAs were identified in adenomyosis compared to infertile controls (5 up- and 6 downregulated), and 23 healthy control-referenced DEmiRNAs compared to fertile controls (19 up- and 4 downregulated). Among disease-specific DEmiRNAs, miR-4433 and miR-652-5p demonstrated strong diagnostic performance for adenomyosis compared to infertile controls (AUC = 0.92 and 0.91, respectively; p < 0.001). For healthy control-referenced DEmiRNAs, 11 miRNAs showed statistically significant diagnostic value (p < 0.01), with the highest AUCs observed for miR-3200-5p, miR-193b-5p, and miR-4732-5p (AUC = 0.88, 0.88 and 0.87, respectively). Validation experiments corroborated the upregulation of miR-4433 and miR-92a-3p upregulation in plasma and endometrium.</p><p><strong>Conclusions: </strong>This study supports the potential of circulating miRNAs as non-invasive biomarkers for adenomyosis and contributes to understanding its molecular basis. The concordance between circulating and endometrial miRNA expression suggests a possible link between systemic molecular alterations and endometrial pathology.</p>","PeriodicalId":21011,"journal":{"name":"Reproductive Biology and Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13629171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书